Key Takeaways & Executive Findings
- •• Q-BioLiP represents protein structures as quaternary structures, capturing interactions across multiple chains that are missed by single-chain tertiary representations. • It properly pairs DNA/RNA chains, addressing the issue of single-chain representation in BioLiP. • The resource includes both experimental and predicted binding affinities, and retains both biologically relevant and irrelevant interactions to reduce misclassification. • A new quaternary structure-based algorithm for protein–ligand complex modeling is provided, enhancing the utility for structure-based studies.
Abstract
Since its establishment in 2013, BioLiP has become one of the widely used resources for protein–ligand interactions. Nevertheless, several known issues occurred with it over the past decade. For example, the protein–ligand interactions are represented in the form of single chain-based tertiary structures, which may be inappropriate as many interactions involve multiple protein chains (known as quaternary structures). We sought to address these issues, resulting in Q-BioLiP, a comprehensive resource for quaternary structure-based protein–ligand interactions. The major features of Q-BioLiP include: (1) representing protein structures in the form of quaternary structures rather than single chain-based tertiary structures; (2) pairing DNA/RNA chains properly rather than separation; (3) providing both experimental and predicted binding affinities; (4) retaining both biologically relevant and irrelevant interactions to alleviate the wrong justification of ligands’ biological relevance; and (5) developing a new quaternary structure-based algorithm for the modelling of protein–ligand complex structure. With these new features, Q-BioLiP is expected to be a valuable resource for studying biomolecule interactions, including protein–small molecule interaction, protein–metal ion interaction, protein–peptide interaction, protein–protein interaction, protein–DNA/RNA interaction, and RNA–small molecule interaction. Q-BioLiP is freely available at https://yanglab.qd.sdu.edu.cn/Q-BioLiP/.
1. Introduction
The biological functions of many proteins are achieved by interacting with other biomolecules, which are referred to as ligands. A collection of high-quality data for protein–ligand interactions is essential to enable related computational studies, such as in the prediction of protein–ligand binding sites, the prediction of binding affinity, and protein–ligand docking. BioLiP is a database that collects 3-dimensional (3D) structures of biologically relevant protein–ligand interactions. It has emerged as one of the most widely used resources for investigating protein–ligand interactions.
There are several known inherent issues with the data in BioLiP. First, the protein structures in BioLiP are represented in single chain-based tertiary structures. Nonetheless, the functional form of many proteins is in quaternary structures, typically comprising multiple interacting chains. Consequently, some vital protein–ligand interactions are not captured in the BioLiP data due to the incompleteness of the protein structure, particularly when a ligand simultaneously interacts with multiple protein chains. For example, the hemoglobin protein can only transport oxygen in the form of a tetramer, which is composed of four chains. Second, DNA ligands in BioLiP are presented in a single-chain format, which is inconsistent with the fact that DNA typically forms a double-helix structure consisting of two complementary chains. The third issue is the potential misjudgement of the biological relevance. BioLiP employs an empirical rule to determine whether a protein–ligand interaction is biologically relevant or not. Consequently, a protein–ligand interaction that is deemed biologically irrelevant is excluded from BioLiP, resulting in the problem of missing data, when a biologically relevant interaction is mistakenly judged as irrelevant.
Loading authentic research manuscript (Pages 1–5)...
Hong Wei, Wenkai Wang, Zhenling Peng, Jianyi Yang (2026). Q-BioLiP: A Comprehensive Resource for Quaternary Structure-based Protein–ligand Interactions. Genomics, Proteomics & Bioinformatics. https://doi.org/10.1093/gpb/art_1126
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is Q-BioLiP?
Q-BioLiP is a comprehensive resource for quaternary structure-based protein–ligand interactions, addressing limitations of the original BioLiP database by representing protein structures as quaternary structures, properly pairing DNA/RNA chains, and including both experimental and predicted binding affinities.
How does Q-BioLiP differ from BioLiP?
Q-BioLiP improves upon BioLiP by using quaternary structures instead of single-chain tertiary structures, pairing DNA/RNA chains, retaining both biologically relevant and irrelevant interactions, and providing a new algorithm for modeling protein–ligand complexes.
What types of interactions are covered in Q-BioLiP?
Q-BioLiP covers protein–small molecule, protein–metal ion, protein–peptide, protein–protein, protein–DNA/RNA, and RNA–small molecule interactions.
Is Q-BioLiP freely available?
Yes, Q-BioLiP is freely available at https://yanglab.qd.sdu.edu.cn/Q-BioLiP/.
What is the significance of using quaternary structures?
Quaternary structures represent the functional form of many proteins, allowing the capture of interactions that involve multiple protein chains, which are missed when using single-chain tertiary structures.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.